Sign inGet started

Kane William P Jr

Insider CIK 1813937 · LBRX Director · BTAI Chief Commercial Officer · KRTX Chief Commercial Officer

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
LBRX LB PHARMACEUTICALS INC A Award deriv2026-06-032026-06-0510,000— $010,000SEC↗
LBRX LB PHARMACEUTICALS INC A Award deriv2025-09-102025-09-1222,449— $022,449SEC↗
KRTX Karuna Therapeutics, Inc. D To issuer deriv2024-03-182024-03-1829,937$137.85 $4.13M0SEC↗
KRTX Karuna Therapeutics, Inc. D To issuer deriv2024-03-182024-03-1810,306$330.00 $3.40M0SEC↗
KRTX Karuna Therapeutics, Inc. D To issuer2024-03-182024-03-185,000$330.00 $1.65M8,828SEC↗
KRTX Karuna Therapeutics, Inc. D To issuer2024-03-182024-03-188,828$330.00 $2.91M0SEC↗
KRTX Karuna Therapeutics, Inc. A Award deriv2024-02-132024-02-1510,306— $010,306SEC↗
KRTX Karuna Therapeutics, Inc. F Tax w/h2023-12-282023-12-293,828$316.30 $1.21M13,828SEC↗
KRTX Karuna Therapeutics, Inc. A Award deriv2023-02-062023-02-0729,937— $029,937SEC↗
KRTX Karuna Therapeutics, Inc. A Award2023-02-062023-02-0717,656— $017,656SEC↗
BTAI BioXcel Therapeutics, Inc. A Award deriv2021-08-162021-08-1840,000— $040,000SEC↗
BTAI BioXcel Therapeutics, Inc. A Award deriv2020-06-152020-06-17110,000— $0110,000SEC↗